What if a polymer could unlock less invasive treatment of brain diseases, like Parkinson’s and Alzheimer’s? These diseases are challenging to treat due to the brain’s intricate system of neurons and synapses, and the risk of harming healthy brain tissue.
Led by Dr. Ya Wang, Texas A&M researchers are testing porous polymers called metal-organic frameworks for targeted drug delivery to affected cells and sites in the brain. These frameworks can be combined with medical imaging to monitor real-time drug delivery, ensuring precise treatment.
This promising polymer technology is leading the way for safe and effective personalized medical treatments.
We’re trying to address the gap for the current technology to address neurological diseases such as Alzheimer’s, Parkinson’s and Huntington’s diseases because the current medication is very difficult to arrive at the brain.
We are the frontline of the medicine community to push that boundary further, as well as to make sure the innovation is actually coming into practice.
